Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 13.07
(0.31%)
CNY 13.07
(0.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 839.07 Million CNY | 81.42% |
| 2022 | 462.51 Million CNY | 46.52% |
| 2021 | 315.66 Million CNY | 689.17% |
| 2020 | 40 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 105 Million CNY | -56.97% |
| 2017 | 244 Million CNY | -69.24% |
| 2016 | 793.1 Million CNY | -59.51% |
| 2015 | 1.95 Billion CNY | -3.36% |
| 2014 | 2.02 Billion CNY | -5.98% |
| 2013 | 2.15 Billion CNY | 299.56% |
| 2012 | 539.5 Million CNY | 912.49% |
| 2011 | 53.28 Million CNY | -77.06% |
| 2010 | 232.28 Million CNY | 105.05% |
| 2009 | 113.28 Million CNY | 79.82% |
| 2008 | 63 Million CNY | 21.15% |
| 2007 | 52 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 757.56 Million CNY | -9.58% |
| 2024 Q3 | 669.46 Million CNY | -9.88% |
| 2024 Q1 | 837.8 Million CNY | -0.15% |
| 2023 Q4 | 839.07 Million CNY | 51.51% |
| 2023 Q1 | 465.14 Million CNY | 0.57% |
| 2023 FY | 839.07 Million CNY | 81.42% |
| 2023 Q2 | 547.45 Million CNY | 17.69% |
| 2023 Q3 | 553.8 Million CNY | 1.16% |
| 2022 FY | 462.51 Million CNY | 46.52% |
| 2022 Q1 | 293.27 Million CNY | -7.09% |
| 2022 Q2 | 413.17 Million CNY | 40.88% |
| 2022 Q3 | 449.35 Million CNY | 8.76% |
| 2022 Q4 | 462.51 Million CNY | 2.93% |
| 2021 Q2 | 199.52 Million CNY | 19.0% |
| 2021 FY | 315.66 Million CNY | 689.17% |
| 2021 Q1 | 167.66 Million CNY | 319.16% |
| 2021 Q4 | 315.66 Million CNY | 43.84% |
| 2021 Q3 | 219.44 Million CNY | 9.99% |
| 2020 FY | 40 Million CNY | 0.0% |
| 2020 Q4 | 40 Million CNY | 0.0% |
| 2020 Q3 | 40 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q2 | 40 Million CNY | 0.0% |
| 2019 Q2 | 180 Million CNY | -5.26% |
| 2019 Q1 | 190 Million CNY | 80.95% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q3 | 120 Million CNY | -33.33% |
| 2019 Q4 | - CNY | -100.0% |
| 2018 Q4 | 105 Million CNY | 0.0% |
| 2018 FY | 105 Million CNY | -56.97% |
| 2018 Q3 | 105 Million CNY | 16.67% |
| 2018 Q2 | 90 Million CNY | -50.0% |
| 2018 Q1 | 180 Million CNY | -26.23% |
| 2017 Q1 | 697.03 Million CNY | -12.11% |
| 2017 FY | 244 Million CNY | -69.24% |
| 2017 Q4 | 244 Million CNY | 0.0% |
| 2017 Q3 | 244 Million CNY | 2.52% |
| 2017 Q2 | 238 Million CNY | -65.86% |
| 2016 Q2 | 1.8 Billion CNY | -6.44% |
| 2016 Q1 | 1.92 Billion CNY | -1.59% |
| 2016 FY | 793.1 Million CNY | -59.51% |
| 2016 Q4 | 793.1 Million CNY | -52.11% |
| 2016 Q3 | 1.65 Billion CNY | -8.16% |
| 2015 FY | 1.95 Billion CNY | -3.36% |
| 2015 Q3 | 1.85 Billion CNY | -0.23% |
| 2015 Q2 | 1.85 Billion CNY | 0.85% |
| 2015 Q4 | 1.95 Billion CNY | 5.71% |
| 2015 Q1 | 1.84 Billion CNY | -9.14% |
| 2014 Q1 | 2.22 Billion CNY | 3.28% |
| 2014 Q4 | 2.02 Billion CNY | -2.11% |
| 2014 FY | 2.02 Billion CNY | -5.98% |
| 2014 Q2 | 2.16 Billion CNY | -2.86% |
| 2014 Q3 | 2.07 Billion CNY | -4.27% |
| 2013 FY | 2.15 Billion CNY | 299.56% |
| 2013 Q4 | 2.15 Billion CNY | 80.19% |
| 2013 Q3 | 1.19 Billion CNY | 66.15% |
| 2013 Q2 | 720 Million CNY | 26.32% |
| 2013 Q1 | 570 Million CNY | 5.65% |
| 2012 Q3 | 360 Million CNY | 575.62% |
| 2012 FY | 539.5 Million CNY | 912.49% |
| 2012 Q4 | 539.5 Million CNY | 49.86% |
| 2012 Q1 | 33.28 Million CNY | -37.53% |
| 2012 Q2 | 53.28 Million CNY | 60.09% |
| 2011 Q3 | 53.28 Million CNY | 0.0% |
| 2011 Q2 | 53.28 Million CNY | 0.0% |
| 2011 Q1 | 53.28 Million CNY | -77.06% |
| 2011 Q4 | 53.28 Million CNY | 0.0% |
| 2011 FY | 53.28 Million CNY | -77.06% |
| 2010 Q2 | 213.28 Million CNY | 0.0% |
| 2010 Q4 | 232.28 Million CNY | 0.0% |
| 2010 FY | 232.28 Million CNY | 105.05% |
| 2010 Q3 | 232.28 Million CNY | 8.91% |
| 2009 FY | 113.28 Million CNY | 79.82% |
| 2008 FY | 63 Million CNY | 21.15% |
| 2007 FY | 52 Million CNY | 0.0% |